![Ryan Robinson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ryan Robinson is currently Treasurer, Chief Financial & Accounting Officer at Tourmaline Sub, Inc. since 2023.
Former roles include Treasurer & Vice President-Finance at Korro Bio, Inc. (United States) from 2020 to 2023, Controller at Jounce Therapeutics, Inc., and Treasurer, Chief Financial & Accounting Officer at Tourmaline Bio, Inc. from 2024 to 2025.
Education includes undergraduate and graduate degrees from Boston College.
| Società | Posizione | Inizio |
|---|---|---|
Tourmaline Bio, Inc.
 Tourmaline Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical biotechnology company developing transformative medicines | Direttore Finanziario/CFO | 01/07/2023 |
| Società | Posizione | Fine |
|---|---|---|
Korro Bio, Inc.
 Korro Bio, Inc. BiotechnologyHealth Technology Develops novel genetic medicines | Treasurer | 01/07/2023 |
| JOUNCE THERAPEUTICS, INC. | Comptroller/Controller/Auditor | - |
Attive
Inattive
Società nel listino
Aziende private
| Aziende private | 4 |
|---|---|
Boston College
 Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Jounce Therapeutics, Inc.
 Jounce Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immunotherapy company that develops therapies to treat cancer | Health Technology |
Korro Bio, Inc.
Korro Bio, Inc. BiotechnologyHealth Technology Develops novel genetic medicines | Health Technology |
Tourmaline Bio, Inc.
Tourmaline Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical biotechnology company developing transformative medicines | Commercial Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
